Literature DB >> 9660326

Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample.

J B Daeppen1, T L Smith, M A Schuckit.   

Abstract

Most clinicians and researchers view serum gamma-glutamyltransferase (GGT) activity as a measure that can be interpreted equally in patients regardless of their demography. The present study evaluates the concurrent influence of age and body mass index (BMI) on GGT in a sample of 133 high functioning young men, with detailed assessment of the pattern of alcohol use at ages 20 [time 1 (T1)], 30 [time 2 (T2)], and 35 [time 3 (T3)]. GGT increased between T1 and T2 (15.4 +/- 9.65 units/liter vs. 20.1 +/- 12.07 units/liter, t = 4.17, p < 0.001), and between T2 and T3 (20.1 +/- 12.07 units/liter vs. 27.3 +/- 24.69 units/liter, t = 4.11, p < 0.001). Controlling for drinking quantity and frequency did not change the finding. The relationship between GGT and BMI was estimated after splitting the sample into normal (BMI < or = 25 kg/m2) and overweight (BMI > 25 kg/m2) subjects. The correlation between GGT and BMI in normal weight men at T1 was r = 0.15, p = 0.09, at T2 r = 0.00, p = 0.96, and at T3 r = 0.09, p = 0.09. In overweight subjects, correlation at T1 was r = 0.40, p = 0.20, at T2 r = 0.36, p < 0.05, and at T3 r = 0.44, p < 0.001. Controlling for the effect of alcohol consumption and/or age did not alter these conclusions. Testing for the interaction of age, BMI, and alcohol consumption did not yield relevant results. We concluded that GGT is positively related to age in the 20s to late 30s and to BMI in overweight subjects; both relationships of age and BMI were independent of alcohol consumption. The interpretation of GGT should take age and BMI into account when suspecting subclinical alcohol problems in young men.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660326

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  8 in total

1.  Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease.

Authors:  Mahmut Ilker Yilmaz; Faruk Turgut; Mehmet Kanbay; Mutlu Saglam; Alper Sonmez; Halil Yaman; Seref Demirbas; Hilmi Umut Unal; Mahmut Gok; Murat Karaman; Seyit Ahmet Ay; Erkan Demirkaya; Adrian Covic; Juan Jesus Carrero
Journal:  Int Urol Nephrol       Date:  2012-12-15       Impact factor: 2.370

Review 2.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Gamma glutamyltransferase levels and its association with high sensitive C-reactive protein in patients with acute coronary syndromes.

Authors:  Mehmet Yunus Emiroglu; Ozlem Batukan Esen; Mustafa Bulut; Hekim Karapinar; Zekeriya Kaya; Mustafa Akcakoyun; Ramazan Kargin; Soe Moe Aung; Elnur Alızade; Selcuk Pala; Ali Metin Esen
Journal:  N Am J Med Sci       Date:  2010-07

4.  Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies.

Authors:  Junna Wang; Dandan Zhang; Rongzhong Huang; Xingsheng Li; Wenxiang Huang
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

5.  In-hospital mortality in SARS-CoV-2 stratified by gamma-glutamyl transferase levels.

Authors:  Moudhi Alroomi; Rajesh Rajan; Ahmad Alsaber; Jiazhu Pan; Mohammed Abdullah; Hassan Abdelnaby; Wael Aboelhassan; Noor AlNasrallah; Bader Al-Bader; Haya Malhas; Maryam Ramadhan; Soumoud Hussein; Naser Alotaibi; Mohammad Al Saleh; Kobalava D Zhanna; Farah Almutairi
Journal:  J Clin Lab Anal       Date:  2022-03-09       Impact factor: 2.352

6.  Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers.

Authors:  Yuka Noborisaka; Masao Ishizaki; Michiko Yamazaki; Ryumon Honda; Yuichi Yamada
Journal:  Nephrourol Mon       Date:  2013-11-13

Review 7.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

8.  Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort.

Authors:  George Khoudari; Amandeep Singh; Mazen Noureddin; Danielle Fritze; Rocio Lopez; Imad Asaad; Eric Lawitz; Fred Poordad; Kris V Kowdley; Naim Alkhouri
Journal:  World J Hepatol       Date:  2019-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.